SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001394548-17-000022
Filing Date
2017-07-06
Accepted
2017-07-06 17:30:06
Documents
1
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6017
  Complete submission text file 0001394548-17-000022.txt   7699
Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Chin Richard (Reporting) CIK: 0001337252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 17953303

Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations